Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael R Hayden Insider Profile
4 Followers
Michael R Hayden, Director at Xenon, holds 322.69K shares in Xenon (Ticker: XENE), holds 39.97K shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Michael R Hayden ― shares of Xenon on ― for an estimated value of ―.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-33.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Michael R Hayden
Michael R Hayden's Trading History
Xenon
―
Director
―
$13.07M
Oxford BioMedica
Nov 14, 2023
Director
Informative Buy
19.28K
$116.32K
List of latest transactions for each holding click on a transaction to see Michael R Hayden's performance on stock
You May Also Like
Michael R Hayden insider profile FAQ
What is the percentage of profitable transactions made by Michael R Hayden?
The percentage of profitable transactions made by Michael R Hayden is 25%.
What is the average return per transaction made by Michael R Hayden?
The average return per transaction made by Michael R Hayden is -33.00%.
What stocks does Michael R Hayden hold?
Michael R Hayden holds: XENE, OXBDF stocks.
What was Michael R Hayden’s latest transaction?
Michael R Hayden latest transaction was an Uninformative Buy of ―.
What was Michael R Hayden's most profitable transaction?
Michael R Hayden’s most profitable transaction was an Informative Buy of OXBDF stock on November 14, 2023. The return on the trade was 10.60%.
What is Michael R Hayden's role in Xenon?
Michael R Hayden's role in Xenon is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.